Fertility and Sterility
Volume 92, Issue 1 , Pages 328-343 , July 2009

Melatonin and the ovary: physiological and pathophysiological implications

  • Hiroshi Tamura, M.D., Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Ube, Japan
    • ,
  • Yasuhiko Nakamura, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Yamaguchi Grand Medical Center, Hofu, Japan
    • ,
  • Ahmet Korkmaz, M.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • ,
  • Lucien C. Manchester, Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • ,
  • Dun-Xian Tan, M.D., Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • ,
  • Norihiro Sugino, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Yamaguchi University Graduate School of Medicine, Ube, Japan
    • ,
  • Russel J. Reiter, Ph.D.

      Affiliations

    • Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
    • Corresponding Author InformationReprint requests: Russel J. Reiter, Ph.D., Department of Cellular and Structural Biology, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900 (FAX: 210-567-6948).

Received 1 February 2008 ,Revised 2 May 2008 ,Accepted 5 May 2008.

References 

  1. Reiter RJ. Melatonin and human reproduction. Ann Med. 1998;30:103–108
  2. Rivara S, Lorenzi S, Mor M, Plazzi PV, Spadoni G, Bedini A, et al. Analysis of structure–activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. J Med Chem. 2005;48:4049–4060
  3. Von Gall C, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 2002;309:151–162
  4. Díaz López B, Díaz Rodríguez E, Urquijo C, Fernández Alvarez C. Melatonin influences on the neuroendocrine-reproductive axis. Ann N Y Acad Sci. 2005;1057:337–364
  5. Barrett P, Conway S, Morgan PJ. Digging deep-structure–function relationships in the melatonin receptor family. J Pineal Res. 2003;35:221–230
  6. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci. 2003;8:1093–1108
  7. Yie SM, Niles LP, Younglai EV. Melatonin receptors on human granulose cell membranes. J Clin Endcrinol Metab. 1995;80:1747–1749
  8. Woo MMM, Tai CJ, Kang SK, Nathwani PM, Pang SF, Leung PCK. Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab. 2001;86:4789–4797
  9. Sugino N, Takiguchi S, Kashida S, Karube A, Nakamura Y, Kato H. Superoxide dismutase expression in the human corpus luteum during the menstrual cycle and in early pregnancy. Mol Hum Reprod. 2000;6:19–25
  10. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28
  11. Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol. 2006;18:325–332
  12. Tan DX, Manchester LC, Sainz RM, Mayo JC, Leon J, Hardeland R, et al. Interaction between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res. 2005;39:185–194
  13. Reiter RJ, Tan DX, Maldonado MD. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res. 2005;39:215–216
  14. Pappolla MA, Chyan YJ, Poeggeler B, Frangione B, Wilson G, Ghiso J, et al. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm. 2000;107:203–231
  15. Bonilla E, Valero N, Chacín-Bonilla L, Medina-Leendertz S. Melatonin and viral infections. J Pineal Res. 2004;36:73–79
  16. Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006;27:1483–1488
  17. Lissoni P. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms. Pathol Biol (Paris). 2007;55:201–204
  18. Ceinos RM, Chansard M, Revel F, Calgari C, Míguez JM, Simonneaux V. Analysis of adrenergic regulation of melatonin synthesis in Siberian hamster pineal emphasizes the role of HIOMT. Neurosignals. 2004;13:308–317
  19. Cassone VM, Natesan AK. Time and time again: the phylogeny of melatonin as a transducer of biological time. J Biol Rhythms. 1997;12:532–534
  20. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab. 1987;64:865–867
  21. Rönnberg L, Kauppila A, Leppäluoto J, Martikainen H, Vakkuri O. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab. 1990;71:492–496
  22. Nakamura Y, Tamura H, Takayama H, Kato H. Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril. 2003;80:1012–1016
  23. Itoh MT, Ishizuka B, Kuribayashi Y, Amemiya A, Sumi Y. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Hum Reprod. 1999;5:402–408
  24. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res. 2003;34:1–10
  25. Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2002;2:181–197
  26. Reiter RJ, Tan DX, Gitto E, Sainz RM, Mayo JC, Leon J, et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol. 2004;56:159–170
  27. Rosen J, Than NN, Koch D, Poeggeler B, Laatsch H, Hardeland R. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res. 2006;41:374–381
  28. Tan DX, Manchester LC, Terron MP, Flores LJD, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and reactive nitrogen species?. J Pineal Res. 2007;42:28–42
  29. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res. 2007;42:386–393
  30. Barlow-Walden LR, Reiter RJ, Abe M, Pablos M, Menendez-Pelaez A, Chen LD, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int. 1995;26:497–502
  31. Pablos MI, Agapito MT, Gutierrez R, Recio JM, Reiter RJ, Barlow-Walden L, et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res. 1995;19:111–115
  32. Ozturk G, Coşkun S, Erbaş D, Hasanoglu E. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol. 2000;50:149–153
  33. Liu F, Ng TB. Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biochem. 2000;78:447–453
  34. Baydas G, Gursu MF, Yilmaz S, Canpolat S, Yasar A, Cikim G, et al. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett. 2002;323:195–198
  35. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004;36:1–9
  36. Antolín I, Rodríguez C, Saínz RM, Mayo JC, Uría H, Kotler ML, et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 1996;10:882–890
  37. Tomás-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res. 2005;39:99–104
  38. Mayo JC, Sainz RM, Antoli I, Herrera F, Martin V, Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci. 2002;59:1706–1713
  39. Mor M, Plazzi PV, Spadoni G, Tarzia G. Melatonin. Curr Med Chem. 1999;6:501–518
  40. Reppert SM. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms. 1997;12:528–531
  41. Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem. 2000;275:31311–31317
  42. Tan DX, Manchester LC, Terron MP, Flores LJ, Tamura H, Reiter RJ. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res. 2007;43:317–320
  43. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev. 1998;78:687–721
  44. Murayama T, Kawashima M, Takahashi T, Yasuoka T, Kuwayama T, Tanaka K. Direct action of melatonin on hen ovarian granulosa cells to lower responsiveness to luteinizing hormone. Proc Soc Exp Bio. 1997;215:386–392
  45. Tamura H, Nakamura Y, Takiguchi S, Kashida S, Yamagata Y, Sugino N, et al. Melatonin directly suppresses steroid production by preovulatory follicles in the cyclic hamster. J Pineal Res. 1998;25:135–141
  46. Webley GE, Leidenberger F. The circadian pattern of melatonin and its positive relationship with progesterone in women. J Clin Endocrinol Metab. 1986;63:323–328
  47. Brzezinski A, Schenker JG, Fibich T, Laufer N, Cohen M. Effects of melatonin on progesterone production by human granulosa lutein cells in culture. Fertil Steril. 1992;58:526–529
  48. Yie SM, Brown GM, Liu GY, Collins JA, Daya S, Hughes EG, et al. Melatonin and steroids in human pre-ovulatory follicular fluid: seasonal variations and granulosa cell steroid production. Hum Reprod. 1995;10:50–55
  49. Niles LP, Wang J, Shen L, Lobb DK, Younglai EV. Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol. 1999;156:107–110
  50. Soares JM, Masana MI, Erşahin C, Dubocovich ML. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J Pharmacol Exp Ther. 2003;306:694–702
  51. Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol. 1991;124:43–101
  52. Wurtman RJ, Axelrod J, Potter LT. The uptake of 3H-melatonin in endocrine and nervous tissues and the effects of constant light exposure. J Pharmacol Exp Ther. 1964;143:314–318
  53. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008;44:280–287
  54. Webb R, Nicholas B, Gong JG, Campbell BK, Gutierrez CG, Garverick HA, et al. Mechanisms regulating follicular development and selection of the dominant follicle. Reprod Suppl. 2003;61:71–90
  55. Drummond AE. The role of steroids in follicular growth. Reprod Biol Endocrinol 200610;4:16.
  56. Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the “two-cell, two-gonadotrophin” model revisited. Mol Cell Endocrinol. 1994;100:51–54
  57. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocrinol Rev. 1997;18:502–519
  58. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes & Dev. 1995;9:2266–2278
  59. Murray AA, Gosden RG, Allison V, Spears N. Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil. 1998;113:27–33
  60. Billig H, Furuta I, Hsueh AJ. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. 1993;133:2204–2212
  61. Adriaens I, Jacquet P, Cortvrindt R, Janssen K, Smitz J. Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. Toxicology. 2006;228:333–343
  62. Tanavde VS, Maitra A. In vitro modulation of steroidogenesis and gene expression by melatonin: a study with porcine antral follicles. Endocrinol Res. 2003;29:399–410
  63. Soares JM, Simões MJ, Oshima CT, Mora OA, De Lima GR, Baracat EC. Pinealectomy changes rat ovarian interstitial cell morphology and decreases progesterone receptor expression. Gynecol Endocrinol. 2003;17:115–123
  64. Wu CS, Leu SF, Yang HY, Huang BM. Melatonin inhibits the expression of steroidogenic acute regulatory protein and steroidogenesis in MA-10 cells. J Androl. 2001;22:245–254
  65. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocrinol Rev. 1999;20:535–582
  66. Chun SY, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsueh AJ. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology. 1994;135:1845–1853
  67. Schaeffer HJ, Sirotkin AV. Melatonin and serotonin regulate the release of insulin-like growth factor-I, oxytocin and progesterone by cultured human granulosa cells. Exp Clin Endocrinol Diabetes. 1997;105:109–112
  68. Picinato MC, Hirata AE, Cipolla-Neto J, Curi R, Carvalho CR, Anhê GF, et al. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res. 2008;44:88–94
  69. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006;132:191–206
  70. Dunkel L, Tilly JL, Shikone T, Nishimori K, Hsueh AJ. Follicle-stimulating hormone receptor expression in the rat ovary: increases during prepubertal development and regulation by the opposing actions of transforming growth factors beta and alpha. Biol Reprod. 1994;50:940–948
  71. Hutchinson LA, Findlay JK, de Vos FL, Robertson DM. Effects of bovine inhibin, transforming growth factor-beta and bovine Activin-A on granulosa cell differentiation. Biochem Biophys Res Commun. 1987;146:1405–1412
  72. Chen YJ, Hsiao PW, Lee MT, Mason JI, Ke FC, Hwang JJ. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J Endocrinol. 2007;192:405–419
  73. Johnson AL, Bridgham JT, Woods DC. Cellular mechanisms and modulation of activin A- and transforming growth factor beta-mediated differentiation in cultured hen granulosa cells. Biol Reprod. 2004;71:1844–1851
  74. Rimler A, Matzkin H, Zisapel N. Cross talk between melatonin and TGFbeta 1 in human benign prostate epithelial cells. Prostate. 1999;40:211–217
  75. Turgut M, Oktem G, Uslu S, Yurtseven ME, Aktuğ H, Uysal A. The effect of exogenous melatonin administration on trabecular width, ligament thickness and TGF-beta(1) expression in degenerated intervertebral disk tissue in the rat. J Clin Neurosci. 2006;13:357–363
  76. Liu F, Ng TB, Fung MC. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J Neural Transm. 2001;108:397–405
  77. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000;275:39523–39528
  78. Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod. 2000;62:370–377
  79. Sugino N, Takiguchi S, Ono M, Tamura H, Shimamura K, Nakamura Y, et al. Nitric oxide concentrations in the follicular fluid and apoptosis of granulosa cells in human follicles. Hum Reprod. 1996;11:2484–2487
  80. Zhang X, Li XH, Ma X, Wang ZH, Lu S, Guo YL. Redox-induced apoptosis of human oocytes in resting follicles in vitro. J Soc Gynecol Investig. 2006;13:451–458
  81. Wu R, Van der Hoek KH, Ryan NK, Norman RJ, Robker RL. Macrophage contributions to ovarian function. Hum Reprod Update. 2004;10:119–133
  82. Halliwell B, Gutteridge JM. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease. Hum Toxicol. 1988;7:7–13
  83. Rapoport R, Sklan D, Hanukoglu I. Electron leakage from the adrenal cortex mitochondrial P450scc and P450c11 systems: NADPH and steroid dependence. Arch Biochem Biophys. 1995;317:412–416
  84. Gupta RK, Miller KP, Babus JK, Flaws JA. Methoxychlor inhibits growth and induces atresia of antral follicles through an oxidative stress pathway. Toxicol Sci. 2006;93:382–389
  85. Tilly JL, Tilly KI. Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles. Endocrinology. 1995;136:242–252
  86. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology. 1995;136:3665–3668
  87. Hsu SY, Lai RJ, Finegold M, Hsueh AJ. Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis, and increased germ cell tumorigenesis. Endocrinology. 1996;137:4837–4843
  88. Matikainen T, Perez GI, Zheng TS, Kluzak TR, Rueda BR, Flavell RA, et al. Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary. Endocrinology. 2001;142:2468–2480
  89. Guha M, Maity P, Choubey V, Mitra K, Reiter RJ, Bandyopadhyay U. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J Pineal Res. 2007;43:372–381
  90. Molpeceres V, Mauriz JL, García-Mediavilla MV, González P, Barrio JP, González-Gallego J. Melatonin is able to reduce the apoptotic liver changes induced by aging via inhibition of the intrinsic pathway of apoptosis. J Gerontol A Biol Sci Med Sci. 2007;62:687–695
  91. Voordouw BC, Euser R, Verdonk RE, Alberda BT, de Jong FH, Drogendijk AC, et al. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab. 1992;74:108–117
  92. Luboshitzky R, Shen-Orr Z, Shochat T, Herer P, Lavie P. Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil. J Mol Neurosci. 1999;12:75–80
  93. Luboshitzky R, Lavie P. Melatonin and sex hormone interrelationships—a review. J Pediatr Endocrinol Metab. 1999;12:355–362
  94. Roy SK, Greenwald GS. In vitro steroidogenesis by primary to antral follicles in the hamster during the periovulatory period: effects of follicle-stimulating hormone, luteinizing hormone, and prolactin. Biol Reprod. 1987;37:39–46
  95. Acosta TJ, Ozawa T, Kobayashi S, Hayashi K, Ohtani M, Kraetzl WD, et al. Periovulatory changes in the local release of vasoactive peptides, prostaglandin f(2alpha), and steroid hormones from bovine mature follicles in vivo. Biol Reprod. 2000;63:1253–1261
  96. Mitchell LM, Kennedy CR, Hartshorne GM. Expression of nitric oxide synthase and effect of substrate manipulation of the nitric oxide pathway in mouse ovarian follicles. Hum Reprod. 2004;19:30–40
  97. Murdoch WJ, Peterson TA, Van Kirk EA, Vincent DL, Inskeep EK. Interactive roles of progesterone, prostaglandins, and collagenase in the ovulatory mechanism of the ewe. Biol Reprod. 1986;35:1187–1194
  98. Cabeza J, Alarcón-de-la-Lastra C, Jiménez D, Martín MJ, Motilva V. Melatonin modulates the effects of gastric injury in rats: role of prostaglandins and nitric oxide. Neurosignals. 2003;12:71–77
  99. Konturek SJ, Zayachkivska O, Havryluk XO, Brzozowski T, Sliwowski Z, Pawlik M, et al. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. J Physiol Pharmacol. 2007;58:361–377
  100. Bettahi I, Guerrero JM, Reiter RJ, Osuna C. Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibiton of nitric oxide synthase. J Pineal Res. 1998;25:34–40
  101. Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod. 1994;50:233–238
  102. Nakamura Y, Smith M, Krishna A, Terranova PF. Increased number of mast cells in the dominant follicle of the cow: relationships among luteal, stromal, and hilar regions. Biol Reprod. 1987;37:546–549
  103. Brännström M, Mayrhofer G, Robertson SA. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol Reprod. 1993;48:277–286
  104. Korzekwa AJ, Okuda K, Woclawek-Potocka I, Murakami S, Skarzynski DJ. Nitric oxide induces apoptosis in bovine luteal cells. J Reprod Dev. 2006;523:353–361
  105. Zuelke KA, Jones DP, Perreault SD. Glutathione oxidation is associated with altered microtubule function and disrupted fertilization in mature hamster oocytes. Biol Reprod. 1997;57:1413–1419
  106. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med. 1999;26:463–471
  107. Noda Y, Matsumoto H, Umaoka Y, Tatsumi K, Kishi J, Mori T. Involvement of superoxide radicals in the mouse two-cell block. Mol Reprod Dev. 1991;28:356–360
  108. Paszkowski T, Traub AI, Robinson SY, McMaster D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta. 1995;236:173–180
  109. Yang HW, Hwang KJ, Kwon HC, Kim HS, Choi KW, Oh KS. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod. 1998;13:998–1002
  110. Paszkowski T, Clarke RN. Antioxidative capacity of preimplantation embryo culture medium declines following the incubation of poor quality embryos. Hum Reprod. 1996;11:2493–2495
  111. Sen U, Mukherjee D, Bhattacharyya SP, Mukherjee D. Seasonal changes in plasma steroid levels in Indian major carp Labeo rohita: influence of homologous pituitary extract on steroid production and development of oocyte maturational competence. Gen Comp Endocrinol. 2002;128:123–134
  112. Nagahama Y. 17, 20-dihydroxy-4-pregnen-3-one, a maturation-inducing hormone in fish oocytes: mechanisms of synthesis and action. Steroids. 1997;62:190–196
  113. Tokumoto T, Tokumoto M, Horiguchi R, Ishikawa K, Nagahama Y. Diethylstilbestrol induces fish oocyte maturation. Proc Natl Acad Sci USA. 2004;101:3686–3690
  114. Chattoraj A, Bhattacharyya S, Basu D, Bhattacharya S, Bhattacharya S, Maitra SK. Melatonin accelerates maturation inducing hormone (MIH): induced oocyte maturation in carps. Gen Comp Endocrinol. 2005;140:145–155
  115. Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin?. J Pineal Res. 2008;44:41–44
  116. Irmak MK, Sizlan A. Essential hypertension seems to result from melatonin-induced epigenetic modifications in area postrema. Med Hypotheses. 2006;66:1000–1007
  117. Irmak MK, Topal T, Oter S. Melatonin seems to be a mediator that transfers the environmental stimuli to oocytes for inheritance of adaptive changes through epigenetic inheritance system. Med Hypotheses. 2005;64:1138–1143
  118. Missbach M, Jagher B, Sigg I, Nayeri S, Carlberg C, Wiesenberg I. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor a with potent antiarthritic activity. J Biol Chem. 1996;271:13515–13522
  119. Smirnov AN. Nuclear melatonin receptors. Biochemistry (Mosc). 2001;66:19–26
  120. Ishizuka B, Kuribayashi Y, Murai K, Amemiya A, Itoh MT. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res. 2000;28:48–51
  121. Rodriguez-Osorio N, Kim IJ, Wang H, Kaya A, Memili E. Melatonin increases cleavage rate of porcine preimplantation embryos in vitro. J Pineal Res. 2007;43:283–288
  122. Abecia JA, Forcada F, Zúñiga O. The effect of melatonin on the secretion of progesterone in sheep and on the development of ovine embryos in vitro. Vet Res Commun. 2002;26:151–158
  123. McElhinny AS, Davis FC, Warner CM. The effect of melatonin on cleavage rate of C57BL/6 and CBA/Ca preimplantation embryos cultured in vitro. J Pineal Res. 1996;21:44–48
  124. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci. 1999;50:271–279
  125. Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: new dimensions and new regulators sponse. Annu Rev Physiol. 2002;64:69–92
  126. Natraj U, Richards JS. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology. 1993;133:761–769
  127. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997;91:197–208
  128. Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW. Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol. 1996;56:67–77
  129. Wetterberg L, Arendt J, Paunier L, Sizonenko PC, Donselaar W, Heyden T. Human serum melatonin changes during the menstrual cycle. J Clin Endocrinol Metab. 1976;42:185–188
  130. Brun J, Claustrat B, David M. Urinary melatonin, LH oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives. Acta Endocrinol (Copenh). 1987;116:145–149
  131. Sirotkin AV. Direct influence of melatonin on steroid, nonapeptide hormones, and cyclic nucleotide secretion by granulosa cells isolated from porcine ovaries. J Pineal Res. 1994;17:112–117
  132. Bódis J, Koppán M, Kornya L, Tinneberg HR, Török A. Influence of melatonin on basal and gonadotropin-stimulated progesterone and estradiol secretion of cultured human granulosa cells and in the superfused granulosa cell system. Gynecol Obstet Invest. 2001;52:198–202
  133. Dair EL, Simoes RS, Simoes MJ, Gomes Romeu LR, Oliveira-Filho RM, Haidar MA, et al. Effects of melatonin on the endometrial morphology and embryo implantation in rats. Fertil Steril. 2008;89:1299–1305
  134. Freeman ME, Smith MS, Nazian SJ, Neill JD. Ovarian and hypothalamic control of the daily surges of prolactin secretion during pseudopregnancy in the rat. Endocrinology. 1974;94:875–882
  135. Okuda K, Sakumoto R. Multiple roles of TNF super family members in corpus luteum function. Reprod Biol Endocrinol. 2003;1:95–104
  136. Webb R, Woad KJ, Armstrong DG. Corpus luteum (CL) function: local control mechanisms. Domest Anim Endocrinol. 2002;23:277–285
  137. Wiltbank MC, Ottobre J. Regulation of intraluteal production of prostaglandins. Reprod Biol Endocrinol. 2003;1:91–101
  138. Stormshak F. Biochemical and endocrine aspects of oxytocin production by the mammalian corpus luteum. Reprod Biol Endocrinol. 2003;1:92–97
  139. Penny LA, Armstrong D, Bramley TA, Webb R, Collins R, Watson ED. Immune cells and cytokine production in the bovine corpus luteum throughout the oestrous cycle and after induced luteolysis. J Reprod Fertil. 1999;115:87–96
  140. Gimeno MF, Landa A, Sterin-Speziale N, Cardinali DP, Gimeno AL. Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus. Eur J Pharmacol. 1980;62:309–317
  141. Deng WG, Tang ST, Tseng HP, Wu KK. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood. 2006;108:518–524
  142. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Molec Neurobiol. 2002;21:605–616
  143. Juszczak M, Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Brain Res Bull. 2003;59:393–397
  144. Plachot M, Belaisch-Allart J, Mayenga JM, Chouraqui A, Tesquier A, Serkine AM, et al. Oocyte and embryo quality in polycystic ovary syndrome. Gynecol Obstet Fertil. 2003;31:350–354
  145. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336–340
  146. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34:407–413
  147. Yildirim B, Demir S, Temur I, Erdemir R, Kaleli B. Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome during assisted reproduction cycles. J Reprod Med. 2007;52:722–726
  148. Sun CL, Qiao J, Hu ZX, Zhang T, Chen YY. Expression of novel apoptosis-related protein PDCD5 in granulosa cells of polycystic ovary syndrome. Beijing Da Xue Xue Bao. 2005;37:476–479
  149. Luboshitzky R, Qupti G, Ishay A, Shen-Orr Z, Futerman B, Linn S. Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome. Fertil Steril. 2001;76:506–510
  150. Cagnacci A, Soldani R, Yen SSC. Exogenous melatonin enhances luteinizing hormone levels of women in the follicular but not in the luteal menstrual phase. Fertil Steril. 1995;63:996–999
  151. Cagnacci A, Paoletti AM, Soldani R, Orru' M, Maschio E, Melis GB. Melatonin enhances the luteinizing hormone and follicle-stimulating hormone response to gonadotropin-releasing hormone in the follicular, but not in the luteal menstrual phase. J Clin Endocrinol Metab. 1995;80:1095–1099
  152. Cagnacci A, Arangino S, Renzi A, Paoletti AM, Melis GB, Cagnacci P, et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol. 2001;54:339–346
  153. Prata Lima MF, Baracat EC, Simões MJ. Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res. 2004;37:987–995
  154. Auwerx J, Staels B. Leptin. Lancet. 1998;351:737–742
  155. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes. 1996;45:1638–1643
  156. Bray GA, York DA. Clinical review 90: leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab. 1997;82:2771–2776
  157. Messinis IE, Milingos SD. Leptin in human reproduction. Hum Reprod Update. 1999;5:52–63
  158. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113:1148–1159
  159. Cervero A, Dominguez F, Horcajadas JA, Quinonero A, Pellicer A, Simon C. The role of the leptin in reproduction. Curr Opin Obstet Gynecol. 2006;18:297–303
  160. Li MG, Ding GL, Chen XJ, Lu XP, Dong LJ, Dong MY, et al. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2007;92:4771–4776
  161. Fedorcsak P, Storeng R, Dale PO, Tanbo T, Torjesen P, Urbancsek J, et al. Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients. Scand J Clin Lab Invest. 2000;60:649–656
  162. Cioffi JA, Van Blerkom J, Antczak M, Shafer A, Wittmer S, Snodgrass HR. The expression of leptin and its receptors in pre-ovulatory human follicles. Mol Hum Reprod. 1997;3:467–472
  163. Brannian JD, Zhao Y, McElroy M. Leptin inhibits gonadotrophin-stimulated granulosa cell progesterone production by antagonizing insulin action. Hum Reprod. 1999;14:1445–1448
  164. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology. 2000;141:487–497
  165. Canpolat S, Sandal S, Yilmaz B, Yasar A, Kutlu S, Baydas G, et al. Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat. Eur J Pharmacol. 2001;428:145–148
  166. Alonso-Vale MI, Andreotti S, Peres SB, Anhê GF, das Neves Borges-Silva C, Neto JC, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab. 2005;288:E805–E812
  167. Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology. 2001;142:4264–4271
  168. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod. 1991;6:544–549
  169. Rawson JM. Prevalence of endometriosis in asymptomatic women. J Reprod Med. 1991;36:513–515
  170. Sangi-Haghpeykar H, Poindexter AN. Epidemiology of endometriosis among parous women. Obstet Gynecol. 1995;85:983–992
  171. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002;77:861–870
  172. Zeller JM, Henig I, Radwanska E, Dmowski WP. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol. 1987;13:78–82
  173. Osborn BH, Haney AF, Misukonis MA, Weinberg JB. Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fretil Steril. 2002;77:46–51
  174. Ozçelik B, Serin IS, Basbug M, Uludag S, Narin F, Tayyar M. Effect of melatonin in the prevention of post-operative adhesion formation in a rat uterine horn adhesion model. Hum Reprod. 2003;18:1703–1706
  175. Güney M, Oral B, Karahan N, Mungan T. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertil Steril. 2008;89:934–942
  176. Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Swarnakar S. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res. 2008;44:439–449
  177. Coulam CB, Adamson DC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–606
  178. Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril. 2005;83:1327–1332
  179. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88:5307–5314
  180. Vijayalaxmi , Reiter RJ, Tan DX, Herman TS, Thomas CR. Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys. 2004;59:639–653
  181. Schuck A, Hamelmann V, Brämswig JH, Könemann S, Rübe C, Hesselmann S, et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol. 2005;181:534–539
  182. Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ. Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum Reprod. 1997;12:2483–2488
  183. Shirazi A, Ghobadi G, Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res (Tokyo). 2007;48:263–272
  184. Badr FM, El Habit OH, Harraz MM. Radioprotective effect of melatonin assessed by measuring chromosomal damage in mitotic and meiotic cells. Mutat Res. 1999;444:367–372
  185. Koc M, Taysi S, Emin Buyukokuroglu M, Bakan N. The effect of melatonin against oxidative damage during total-body irradiation in rats. Radiat Res. 2003;160:251–255
  186. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod. 1993;8:2080–2087
  187. Lissoni P, Barni S, Mandalà M, Ardizzoia A, Paolorossi F, Vaghi M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer. 1999;35:1688–1692
  188. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol. 2002;54:1299–1321
  189. Oz E, Erbaş D, Sürücü HS, Düzgün E. Prevention of doxorubicin-induced cardiotoxicity by melatonin. Mol Cell Biochem. 2006;282:31–37
  190. Reiter RJ, Tan DX, Sainz RM, Mayo JC. Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs. Cardiovasc Drugs Ther. 2002;16:5–6
  191. Conway GS. Clinical manifestations of genetic defects affecting gonadotrophins and their receptors. Clin Endocrinol (Oxf). 1996;45:657–663
  192. Narayanan M, Murthy PS, Munaf SA, Shah LC, Kini MD. Antiovarian antibodies and their effect on the outcome of assisted reproduction. J Assist Reprod Genetics. 1995;12:599–605
  193. Nandedkar TD, Wadia P. Autoimmune disorders of the ovary. Indian J Exper Biol. 1998;36:433–436
  194. Luborsky J, Llanes B, Davies S, Binor Z, Radwanska E, Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol. 1999;90:368–374
  195. Nelson LM, Kimzey LM, Merriam GR, Fleisher TA. Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil Steril. 1991;55:1082–1087
  196. Monnier-Barbarino P, Forges T, Faure GC, Bene MC. Gonadal antibodies interfering with female reproduction. Best Pract Res Clin Endocrinol Metab. 2005;19:135–148
  197. Drexhage HA, Bottazzo GF, Bitensky L, Chayen J, Doniach D. Thyroid growth-blocking antibodies in primary myxoedema. Nature. 1981;289:594–596
  198. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem. 2002;2:167–179
  199. Carrillo-Vico A, García-Mauriño S, Calvo JR, Guerrero JM. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J. 2003;17:755–777
  200. García-Pergañeda A, Pozo D, Guerrero JM, Calvo JR. Signal transduction for melatonin in human lymphocytes: Involvement of a pertussis-toxin sensitive G protein. J Immunol. 1997;159:3774–3781
  201. Barjavel MJ, Mamdouh Z, Raghbate N, Bakouche O. Differential expression of the melatonin receptor in human monocytes. J Immunol. 1998;160:1191–1197
  202. Srinivasan V, Maestroni GJ, Cardinali DP, Esquifino AI, Perumal SR, Miller SC. Melatonin, immune function and aging. Immun Ageing. 2005;2:17
  203. Petrovsky N, Harrison L. The chronobiology of human cytokine production. Int Rev Immunol. 1998;16:635–649
  204. Raghavendra V, Singh V, Kulkarni SK, Agrewala JN. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem. 2001;221:57–62
  205. Kang JC, Ahn M, Kim YS, Moon C, Lee Y, Wie MB, et al. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1. J Vet Sci. 2001;2:85–89
  206. Voznesenskaya T, Makogon N, Bryzgina T, Sukhina V, Grushka N, Alexeyeva I. Melatonin protects against experimental immune ovarian failure in mice. Reprod Biol. 2007;7:207–220
  207. Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ. 2006;332:385–393
  208. Jan JE, Wasdell MB, Reiter RJ, Weiss MD, Johnson KP, Ivanenko A, et al. Melatonin in therapy at pediatric sleep disorders: recent advances, why it works, who are the candidates and how to treat. Curr Pediatr Rev. 2007;3:214–224

 H.T. has nothing to disclose. Y.N. has nothing to disclose. A.K. has nothing to disclose. L.C.M. has nothing to disclose. D.-X.T. has nothing to disclose. N.S. has nothing to disclose. R.J.R. has nothing to disclose.

PII: S0015-0282(08)01130-8

doi: 10.1016/j.fertnstert.2008.05.016

Fertility and Sterility
Volume 92, Issue 1 , Pages 328-343 , July 2009

Article Tools

* Image Usage & Resolution